Sophiris Bio reports fourth quarter and full year 2016 financial results
Sophiris Bio reported a net loss of $11.2 million ($0.49 per share) for the 2016 year end compared to a net loss of $14.2 million ($0.84 per share) in 2015. At Dec. 31, 2016, the Company had cash and equivalents of $29.0 million. March 27, 2017